
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Calcium, mitochondrial dysfunction and slowing the progression of Parkinson's disease
D. James Surmeier, Glenda M. Halliday, Tanya Simuni
Experimental Neurology (2017) Vol. 298, pp. 202-209
Open Access | Times Cited: 80
D. James Surmeier, Glenda M. Halliday, Tanya Simuni
Experimental Neurology (2017) Vol. 298, pp. 202-209
Open Access | Times Cited: 80
Showing 1-25 of 80 citing articles:
On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease
Nicolas Giguère, Samuel Burke Nanni, Louis‐Éric Trudeau
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 348
Nicolas Giguère, Samuel Burke Nanni, Louis‐Éric Trudeau
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 348
New insights into the complex role of mitochondria in Parkinson’s disease
Anne Grünewald, Kishore R. Kumar, Carolyn M. Sue
Progress in Neurobiology (2018) Vol. 177, pp. 73-93
Open Access | Times Cited: 332
Anne Grünewald, Kishore R. Kumar, Carolyn M. Sue
Progress in Neurobiology (2018) Vol. 177, pp. 73-93
Open Access | Times Cited: 332
Role of DJ-1 in the mechanism of pathogenesis of Parkinson's disease
Л. П. Долгачева, Alexey V. Berezhnov, Evgeniya I. Fedotova, et al.
Journal of Bioenergetics and Biomembranes (2019) Vol. 51, Iss. 3, pp. 175-188
Open Access | Times Cited: 205
Л. П. Долгачева, Alexey V. Berezhnov, Evgeniya I. Fedotova, et al.
Journal of Bioenergetics and Biomembranes (2019) Vol. 51, Iss. 3, pp. 175-188
Open Access | Times Cited: 205
Parkinson’s disease from the gut
Rodger A. Liddle
Brain Research (2018) Vol. 1693, pp. 201-206
Open Access | Times Cited: 182
Rodger A. Liddle
Brain Research (2018) Vol. 1693, pp. 201-206
Open Access | Times Cited: 182
Novel Approaches for the Treatment of Alzheimer’s and Parkinson’s Disease
Michiel Van Bulck, Ana Sierra‐Magro, Jesús Alarcón-Gil, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 3, pp. 719-719
Open Access | Times Cited: 154
Michiel Van Bulck, Ana Sierra‐Magro, Jesús Alarcón-Gil, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 3, pp. 719-719
Open Access | Times Cited: 154
The Role of the Gut Microbiota in the Pathogenesis of Parkinson's Disease
Dongming Yang, Deming Zhao, Syed Zahid Ali Shah, et al.
Frontiers in Neurology (2019) Vol. 10
Open Access | Times Cited: 129
Dongming Yang, Deming Zhao, Syed Zahid Ali Shah, et al.
Frontiers in Neurology (2019) Vol. 10
Open Access | Times Cited: 129
Systemic isradipine treatment diminishes calcium-dependent mitochondrial oxidant stress
Jaime N. Guzmán, Ema Ilijić, Ben Yang, et al.
Journal of Clinical Investigation (2018) Vol. 128, Iss. 6, pp. 2266-2280
Open Access | Times Cited: 123
Jaime N. Guzmán, Ema Ilijić, Ben Yang, et al.
Journal of Clinical Investigation (2018) Vol. 128, Iss. 6, pp. 2266-2280
Open Access | Times Cited: 123
The Potential of L-Type Calcium Channels as a Drug Target for Neuroprotective Therapy in Parkinson's Disease
Birgit Liss, Jörg Striessnig
The Annual Review of Pharmacology and Toxicology (2019) Vol. 59, Iss. 1, pp. 263-289
Closed Access | Times Cited: 95
Birgit Liss, Jörg Striessnig
The Annual Review of Pharmacology and Toxicology (2019) Vol. 59, Iss. 1, pp. 263-289
Closed Access | Times Cited: 95
Calcium-Handling Defects and Neurodegenerative Disease
Sean Schrank, Nikki M. Barrington, Grace E. Stutzmann
Cold Spring Harbor Perspectives in Biology (2019) Vol. 12, Iss. 7, pp. a035212-a035212
Open Access | Times Cited: 89
Sean Schrank, Nikki M. Barrington, Grace E. Stutzmann
Cold Spring Harbor Perspectives in Biology (2019) Vol. 12, Iss. 7, pp. a035212-a035212
Open Access | Times Cited: 89
Cav2.3 channels contribute to dopaminergic neuron loss in a model of Parkinson’s disease
Julia Benkert, Simon Heß, Shoumik Roy, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 82
Julia Benkert, Simon Heß, Shoumik Roy, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 82
Mechanisms of Mitochondrial Dysfunction in Lysosomal Storage Disorders: A Review
Karolina M. Stępień, Federico Roncaroli, Nadia Turton, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 8, pp. 2596-2596
Open Access | Times Cited: 76
Karolina M. Stępień, Federico Roncaroli, Nadia Turton, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 8, pp. 2596-2596
Open Access | Times Cited: 76
Oxidative stress and synaptic dysfunction in rodent models of Parkinson's disease
Paola Imbriani, Giuseppina Martella, Paola Bonsi, et al.
Neurobiology of Disease (2022) Vol. 173, pp. 105851-105851
Open Access | Times Cited: 39
Paola Imbriani, Giuseppina Martella, Paola Bonsi, et al.
Neurobiology of Disease (2022) Vol. 173, pp. 105851-105851
Open Access | Times Cited: 39
T-type Calcium Channels Determine the Vulnerability of Dopaminergic Neurons to Mitochondrial Stress in Familial Parkinson Disease
Yoshikuni Tabata, Yoichi Imaizumi, Michiko SUGAWARA, et al.
Stem Cell Reports (2018) Vol. 11, Iss. 5, pp. 1171-1184
Open Access | Times Cited: 79
Yoshikuni Tabata, Yoichi Imaizumi, Michiko SUGAWARA, et al.
Stem Cell Reports (2018) Vol. 11, Iss. 5, pp. 1171-1184
Open Access | Times Cited: 79
Calcium, Bioenergetics, and Parkinson’s Disease
Enrico Zampese, D. James Surmeier
Cells (2020) Vol. 9, Iss. 9, pp. 2045-2045
Open Access | Times Cited: 60
Enrico Zampese, D. James Surmeier
Cells (2020) Vol. 9, Iss. 9, pp. 2045-2045
Open Access | Times Cited: 60
Targeting α-Synuclein for PD Therapeutics: A Pursuit on All Fronts
Margaux Teil, Marie-Laure Arotçarena, Emilie Faggiani, et al.
Biomolecules (2020) Vol. 10, Iss. 3, pp. 391-391
Open Access | Times Cited: 55
Margaux Teil, Marie-Laure Arotçarena, Emilie Faggiani, et al.
Biomolecules (2020) Vol. 10, Iss. 3, pp. 391-391
Open Access | Times Cited: 55
Toxic Exposure to Endocrine Disruptors Worsens Parkinson’s Disease Progression through NRF2/HO-1 Alteration
Ramona D’Amico, Enrico Gugliandolo, Rosalba Siracusa, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1073-1073
Open Access | Times Cited: 28
Ramona D’Amico, Enrico Gugliandolo, Rosalba Siracusa, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1073-1073
Open Access | Times Cited: 28
PINK1 and Parkin regulate IP3R-mediated ER calcium release
Su Jin Ham, Heesuk Yoo, Daihn Woo, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 20
Su Jin Ham, Heesuk Yoo, Daihn Woo, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 20
ER Ca2+ overload activates the IRE1α signaling and promotes cell survival
Song Zhao, Haiping Feng, Dongfang Jiang, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 17
Song Zhao, Haiping Feng, Dongfang Jiang, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 17
Mitochondria and α-Synuclein: Friends or Foes in the Pathogenesis of Parkinson’s Disease?
Gaia Faustini, Federica Bono, Alessandra Valerio, et al.
Genes (2017) Vol. 8, Iss. 12, pp. 377-377
Open Access | Times Cited: 58
Gaia Faustini, Federica Bono, Alessandra Valerio, et al.
Genes (2017) Vol. 8, Iss. 12, pp. 377-377
Open Access | Times Cited: 58
Centrality of Early Synaptopathy in Parkinson’s Disease
Paola Imbriani, Tommaso Schirinzi, Maria Meringolo, et al.
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 48
Paola Imbriani, Tommaso Schirinzi, Maria Meringolo, et al.
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 48
Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson’s Disease
Gagandeep Kaur, Tapan Behl, Simona Bungău, et al.
Current Neuropharmacology (2020) Vol. 19, Iss. 2, pp. 233-247
Open Access | Times Cited: 46
Gagandeep Kaur, Tapan Behl, Simona Bungău, et al.
Current Neuropharmacology (2020) Vol. 19, Iss. 2, pp. 233-247
Open Access | Times Cited: 46
Isradipine plasma pharmacokinetics and exposure–response in early Parkinson’s disease
Charles S. Venuto, Luoying Yang, Monica Javidnia, et al.
Annals of Clinical and Translational Neurology (2021) Vol. 8, Iss. 3, pp. 603-612
Open Access | Times Cited: 39
Charles S. Venuto, Luoying Yang, Monica Javidnia, et al.
Annals of Clinical and Translational Neurology (2021) Vol. 8, Iss. 3, pp. 603-612
Open Access | Times Cited: 39
The Role of Voltage-Gated Calcium Channels in Basal Ganglia Neurodegenerative Disorders
Bernardo Henrique Mendes Correa, Carlos Roberto Moreira, Michael E. Hildebrand, et al.
Current Neuropharmacology (2022) Vol. 21, Iss. 2, pp. 183-201
Open Access | Times Cited: 23
Bernardo Henrique Mendes Correa, Carlos Roberto Moreira, Michael E. Hildebrand, et al.
Current Neuropharmacology (2022) Vol. 21, Iss. 2, pp. 183-201
Open Access | Times Cited: 23
Drug Repurposing in Parkinson’s Disease
Dilan Athauda, Thomas Foltynie
CNS Drugs (2018) Vol. 32, Iss. 8, pp. 747-761
Closed Access | Times Cited: 46
Dilan Athauda, Thomas Foltynie
CNS Drugs (2018) Vol. 32, Iss. 8, pp. 747-761
Closed Access | Times Cited: 46
Mutation of hop-1 and pink-1 attenuates vulnerability of neurotoxicity in C. elegans: the role of mitochondria-associated membrane proteins in Parkinsonism
Siyu Wu, Lili Lei, Yang Song, et al.
Experimental Neurology (2018) Vol. 309, pp. 67-78
Open Access | Times Cited: 44
Siyu Wu, Lili Lei, Yang Song, et al.
Experimental Neurology (2018) Vol. 309, pp. 67-78
Open Access | Times Cited: 44